University of Georgia

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Georgia sits in the top decile of US sponsors by registered trial count (#338 of 15,742 sponsors by registered trial count).

59 total trials 12 currently recruiting 42 completed early-phase tilt top decile by trial count

University of Georgia: 59 sponsored US clinical trials, 12 recruiting.

University of Georgia sponsors 59 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 42 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Nutrition, Healthy, with 4 trials.

Top-decile sponsor footprint

University of Georgia ranks in the top decile of sponsors by registered trial count (#338 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

42 of 42 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

59 total, page 2 of 2

COMPLETED NA

The Effects of a Zeaxanthin Intervention on Visuomotor Function

NCT02017418
COMPLETED NA

Effect of a High-Protein Diet and/or High-Intensity Training on Metabolic Syndrome

NCT01622634
COMPLETED NA

Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes

NCT02134119
COMPLETED NA

D-Cycloserine to Enhance Extinction to Alcohol Cues

NCT01362309
COMPLETED NA

Vitamin D Needs of Early Adolescent Children

NCT00931580
COMPLETED NA

Exercise Training for the Treatment of Generalized Anxiety Disorder

NCT00953654
COMPLETED

Human Papilloma Virus (HPV) Vaccination Among Rural African American Primary Caregivers and Daughters

NCT00937287
COMPLETED NA

Macular Pigment and Glare Disability

NCT00909090
COMPLETED NA

Soy, Bone and Health in College Females

NCT00244478
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Therapeutic Areas

Nutrition, Healthy 4
Overweight and Obesity 4
Dyslipidemia 2
Healthy 2
Dyslipidemias 2
Cerebral Palsy, Spastic 1
Traumatic Stress Disorder 1
No Message Exposure (Control Condition) 1
Message Exposure (Sequence: Flavor Then Regular) 1
Message Exposure (Sequence: Regular Then Flavor) 1

What is open in the University of Georgia pipeline

12 recruiting of 59 indexed (20% open); 42 completed (71%).

Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Nutrition, Healthy (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Georgia: open-pipeline peers nationwide

Peers matched on 59 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

University of Georgia sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 0%5%10%15%20%25% Total trials Recruiting share University of GeorgiaClinical Nutrition Research Center, Illinois Institute of TechnologyUnited States Army Research Institute of Environmental MedicineWills EyeHenry M. Jackson Foundation for the Advancement of Military MedicineUniversity of HoustonThe University of Texas Health Science Center at San AntonioM.D. Anderson Cancer CenterFlorida International University
University of Georgia sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Georgia sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 59 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Georgia page

59 registered trials is a research-attention snapshot, not an endorsement of University of Georgia or any single study.

  • 12 of University of Georgia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Nutrition, Healthy is the condition University of Georgia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Nutrition, Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Georgia pipeline card: 59 registered trials from official public datasets.Report a data error.